Preliminary studies from our research showed that knockdown of VPS34 by siRNA in PAVSMC from patients with PAH was associated with increased TSC2 and consequent mTOR inactivation, decreased accumulation of VPS15, and decreased proliferation and survival [20]. This evidence concerns the gene PIK3C3 and pulmonary arterial hypertension.